Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey.


Basaran G., Demirci U. , Yildiz F., Cicin I., Aktas B. Y. , Ozturk B., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.38, 2020 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 38 Konu: 15
  • Basım Tarihi: 2020
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY